Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)

Completed · Phase 2

Conditions studied: Rheumatoid Arthritis

In brief

Using repeated arthroscopic biopsies of patients with rheumatoid arthritis, the researchers will assess changes in the immune response that occur as a result of treatment with rituximab.

Key facts

Study ID

NCT00147966

Run by

University of California, San Diego

People needed

24

Starts

2008-06-01

Expected to finish

2009-12-01

Last updated by the study team

2010-03-23

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Active rheumatoid arthritis
• Use of concomitant methotrexate

You may not qualify if…

• Use of disease-modifying anti-rheumatic drugs (DMARDs)/biologics other than methotrexate
• Serious medical conditions that would preclude the use of the treating agent

Where it is running

• UCSD CIT — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.